<- Go Home
Allergan plc
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide.
Market Cap
$63.7B
Volume
3.3M
Cash and Equivalents
$999.5M
EBITDA
$7.2B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$13.5B
Profit Margin
84.13%
52 Week High
$202.22
52 Week Low
$114.27
Dividend
N/A
Price / Book Value
1.10
Price / Earnings
-25.50
Price / Tangible Book Value
-3.26
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$1.1B
Return on Equity
-4.15%
Return on Assets
0.74
Cash and Short Term Investments
$2.6B
Debt
$20.1B
Equity
$58.0B
Revenue
$16.1B
Unlevered FCF
$6.9B
Sector
Pharmaceuticals
Category
N/A